Accuracy of Index Lymph Node Pathology in Predicting Overall Response to Neoadjuvant Immunotherapy for Clinical Stage III Melanoma: Results From the Prospective NeoACTIVATE Arm C (NCT03554083) Substudy.

Saved in:
Bibliographic Details
Title: Accuracy of Index Lymph Node Pathology in Predicting Overall Response to Neoadjuvant Immunotherapy for Clinical Stage III Melanoma: Results From the Prospective NeoACTIVATE Arm C (NCT03554083) Substudy.
Authors: Hieken TJ; Division of Breast and Melanoma Surgical Oncology, Department of Surgery, Mayo Clinic, Rochester, MN, USA. hieken.tina@mayo.edu.; Mayo Clinic Comprehensive Cancer Center, Rochester, MN, USA. hieken.tina@mayo.edu., Flotte TJ; Mayo Clinic Comprehensive Cancer Center, Rochester, MN, USA.; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA., Zahrieh D; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA., Johnson JE; Division of Breast and Melanoma Surgical Oncology, Department of Surgery, Mayo Clinic, Rochester, MN, USA., Piltin MA; Division of Breast and Melanoma Surgical Oncology, Department of Surgery, Mayo Clinic, Rochester, MN, USA., Tasche KK; Department of Otolaryngology, Mayo Clinic, Rochester, MN, USA., Nelson GD; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA., Strand CA; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA., Jakub JW; Department of Surgery, Mayo Clinic, Jacksonville, FL, USA., Pirgousis P; Department of Otorhinolaryngology, Mayo Clinic, Jacksonville, FL, USA., Khariwala SS; Department of Otolaryngology, University of Minnesota, Minneapolis, MN, USA., Tuttle T; Division of Surgical Oncology, Department of Surgery, University of Minnesota, Minneapolis, MN, USA., Block MS; Mayo Clinic Comprehensive Cancer Center, Rochester, MN, USA.; Department of Oncology, Mayo Clinic, Rochester, MN, USA.
Source: Annals of surgical oncology [Ann Surg Oncol] 2026 Aug; Vol. 33 (8), pp. 7471-7476. Date of Electronic Publication: 2026 May 30.
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study
Journal Info: Publisher: Springer Country of Publication: United States NLM ID: 9420840 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1534-4681 (Electronic) Linking ISSN: 10689265 NLM ISO Abbreviation: Ann Surg Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1534-4681
DOI:10.1245/s10434-026-19899-1